Davis Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $28.5K | Hold |
352
| – | – | 0.02% | 170 |
|
|
2024
Q4 | $31.7K | Hold |
352
| – | – | 0.03% | 164 |
|
|
2024
Q3 | $34.8K | Hold |
352
| – | – | 0.03% | 165 |
|
|
2024
Q2 | $32.8K | Hold |
352
| – | – | 0.03% | 165 |
|
|
2024
Q1 | $33K | Hold |
352
| – | – | 0.03% | 159 |
|
|
2023
Q4 | $31.4K | Buy |
+352
| New | +$31.4K | 0.03% | 156 |
|
|
2020
Q2 | $39K | Hold |
352
| – | – | 0.07% | 117 |
|
|
2020
Q1 | $27K | Buy |
+352
| New | +$27K | 0.06% | 133 |
|